Lawrence Arky, MD
Obstetrics & Gynecology · Manchester, CTNPI 1124122338
Payments from drug & device makers
Across 58 payments — averaging $19.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exeltis, USA Inc.$140
- Coopersurgical, Inc.$137
- Astellas Pharma US Inc$128
- Merck$81
- AbbVie$81
- Organon$72
- plus $485 from 15 others
What the payments were for
- Food & beverage$1,125100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exeltis, USA Inc. | 7 | $140 |
| Coopersurgical, Inc. | 7 | $137 |
| Astellas Pharma US Inc | 5 | $128 |
| Merck | 5 | $81 |
| AbbVie(2 entities) | 4 | $81 |
| Organon | 4 | $72 |
| Therapeuticsmd, Inc. | 4 | $67 |
| Bayer | 4 | $65 |
| Exact Sciences | 2 | $54 |
| Duchesnay USA Incorporated | 2 | $47 |
| Minerva Surgical, Inc | 2 | $37 |
| Myovant Sciences Inc. | 2 | $29 |
| Mayne Pharma Commercial LLC | 1 | $27 |
| Lupin Inc. | 2 | $26 |
| Johnson & Johnson | 1 | $25 |
| Siemens Medical Solutions USA, Inc. | 1 | $22 |
| Covidien LP | 1 | $21 |
| Urovant Sciences Inc | 1 | $20 |
| Sage Therapeutics, LLC | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| Avion Pharmaceuticals | 1 | $13 |
How this compares
$1,125 in reported general payments places this provider in the 70th percentile of 605 obstetrics & gynecology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 37 | $2,212 |
| ValacyclovirValacyclovir Hcl | 16 | $857 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $297 |
| Clobetasol Propionate | 16 | $137 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Manchester
- Daniel WellingManchester$63K
- Alessandro SantinNew Haven$14.1M
- Mark LeondiresNorwalk$1.4M
- Alan FineHartford$974K
- Mary MinkinNew Haven$285K
- Elena RatnerNew Haven$119K
- Frederick RauHartford$89K
- Peter AuerbachGroton$41K
- Sangini ShethNew Haven$39K
- Shieva GhofranyStamford$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.